BCHE and Alzheimer disease: BChE inhibitors may also have a role in the treatment of AD in the future, mainly due to the introduction of the multi-target-directed ligand (MTDL) design strategies for the development of the molecules capable of simultaneously modulating multiple pathways in the neurodegenerative cascade [13,14].